Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation
Author:
Publisher
Elsevier BV
Subject
Toxicology,General Medicine
Reference20 articles.
1. Survivin, cancer networks and pathway-directed drug discovery;Altieri;Nat. Rev. Cancer,2008
2. Estrogen receptor prevents p53-dependent apoptosis in breast cancer;Bailey;Proc. Natl. Acad. Sci. U. S. A.,2012
3. Is NF-κB a good target for cancer therapy? Hopes and pitfalls;Baud;Nat. Rev. Drug Discov.,2009
4. Salinomycin: a new paradigm in cancer therapy;Dewangan;Tumor Biol.,2017
5. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells;Fuchs;Biochem. Biophys. Res. Commun.,2010
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production;Chemico-Biological Interactions;2024-11
2. Elucidating the Intricate Roles of Gut and Breast Microbiomes in Breast Cancer Metastasis to the Bone;Cancer Reports;2024-08
3. NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges;Life Sciences;2024-07
4. Inhibition of Wnt/β-catenin signaling by monensin in cervical cancer;The Korean Journal of Physiology & Pharmacology;2024-01-01
5. Salinomycin and IR780-loaded upconversion nanoparticles influence biological behavior of liver cancer stem cells by persistently activating the MAPK signaling pathway;Experimental Cell Research;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3